Literature DB >> 15380513

Focus on kidney cancer.

W Marston Linehan1, Berton Zbar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15380513     DOI： 10.1016/j.ccr.2004.09.006

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


× No keyword cloud information.
  48 in total

1.  The NIH Clinical Center and the future of clinical research.

Authors:  John I Gallin
Journal:  Nat Med       Date:  2011-10-11       Impact factor: 53.440

2.  FoxOs enforce a progression checkpoint to constrain mTORC1-activated renal tumorigenesis.

Authors:  Boyi Gan; Carol Lim; Gerald Chu; Sujun Hua; Zhihu Ding; Michael Collins; Jian Hu; Shan Jiang; Eliot Fletcher-Sananikone; Li Zhuang; Michelle Chang; Hongwu Zheng; Y Alan Wang; David J Kwiatkowski; William G Kaelin; Sabina Signoretti; Ronald A DePinho
Journal:  Cancer Cell       Date:  2010-11-16       Impact factor: 31.743

3.  Translocation renal cell carcinomas in adults: a single-institution experience.

Authors:  Minghao Zhong; Patricia De Angelo; Lisa Osborne; Alberto E Paniz-Mondolfi; Matthew Geller; Youfeng Yang; W Marston Linehan; Maria J Merino; Carlos Cordon-Cardo; Dongming Cai
Journal:  Am J Surg Pathol       Date:  2012-05       Impact factor: 6.394

4.  EGFR mRNA is upregulated, but somatic mutations of the gene are hardly found in renal cell carcinoma in Japanese patients.

Authors:  Toshiyuki Sakaeda; Noboru Okamura; Akinobu Gotoh; Toshiro Shirakawa; Shuji Terao; Masahi Morioka; Kenji Tokui; Hisato Tanaka; Tsutomu Nakamura; Mariko Yagi; Yoshihiro Nishimura; Mitsuhiro Yokoyama; Katsuhiko Okumura
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

5.  Conditional survival in patients treated with vascular endothelial growth factor-targeted therapy for advanced renal cell carcinoma.

Authors:  Y Zhu; Y P Hong; H L Zhang; G H Shi; W J Xiao; Z H Wang; X D Yao; S L Zhang; B Dai; D W Ye
Journal:  J Cancer Res Clin Oncol       Date:  2012-06-29       Impact factor: 4.553

6.  FoxO transcription factors promote AKT Ser473 phosphorylation and renal tumor growth in response to pharmacologic inhibition of the PI3K-AKT pathway.

Authors:  Aifu Lin; Hai-Long Piao; Li Zhuang; Dos D Sarbassov; Li Ma; Boyi Gan
Journal:  Cancer Res       Date:  2014-01-21       Impact factor: 12.701

Review 7.  The clinical implications of the genetics of renal cell carcinoma.

Authors:  Inger Rosner; Gennady Bratslavsky; Peter A Pinto; W Marston Linehan
Journal:  Urol Oncol       Date:  2009 Mar-Apr       Impact factor: 3.498

8.  Renal Tumor Quantification and Classification in Contrast-Enhanced Abdominal CT.

Authors:  Marius George Linguraru; Jianhua Yao; Rabindra Gautam; James Peterson; Zhixi Li; W Marston Linehan; Ronald M Summers
Journal:  Pattern Recognit       Date:  2009-06-01       Impact factor: 7.740

Review 9.  Hereditary kidney cancer: unique opportunity for disease-based therapy.

Authors:  W Marston Linehan; Peter A Pinto; Gennady Bratslavsky; Elizabeth Pfaffenroth; Maria Merino; Cathy D Vocke; Jorge R Toro; Donald Bottaro; Len Neckers; Laura S Schmidt; Ramaprasad Srinivasan
Journal:  Cancer       Date:  2009-05-15       Impact factor: 6.860

Review 10.  Biology of urothelial tumorigenesis: insights from genetically engineered mice.

Authors:  Xue-Ru Wu
Journal:  Cancer Metastasis Rev       Date:  2009-12       Impact factor: 9.264
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.